22nd week of 2016 patent applcation highlights part 8 |
Patent application number | Title | Published |
20160151423 | METHODS, COMPOSITIONS, AND KITS FOR IMPROVING PANCREATIC BETA CELL VIABILITY AND TREATING DISEASES OR CONDITIONS RELATED TO BETA CELL DESTRUCTION | 2016-06-02 |
20160151424 | AMNIOTIC MEMBRANE PREPARATIONS AND PURIFIED COMPOSITIONS AND ANTI-INFLAMMATION METHODS | 2016-06-02 |
20160151425 | METHODS AND COMPOSITIONS FOR TREATMENT OF BONE DEFECTS WITH PLACENTAL CELL POPULATIONS | 2016-06-02 |
20160151426 | PREPARATION OF BEE VENOM WITH ALLERGENIC COMPONENTS REMOVED | 2016-06-02 |
20160151427 | AMMONIA OXIDIZING BACTERIA FOR TREATMENT OF ACNE | 2016-06-02 |
20160151428 | COMPOSITIONS AND METHODS FOR PROMOTING NITRIC OXIDE PRODUCTION THROUGH AN ORAL DELIVERY SYSTEM | 2016-06-02 |
20160151429 | PROBIOTIC RECOLONISATION THERAPY | 2016-06-02 |
20160151430 | COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS | 2016-06-02 |
20160151431 | PROBIOTIC RECOLONISATION THERAPY | 2016-06-02 |
20160151432 | PROBIOTIC RECOLONISATION THERAPY | 2016-06-02 |
20160151433 | PROBIOTIC RECOLONISATION THERAPY | 2016-06-02 |
20160151434 | NOVEL LACTOBACILLUS PLANTARUM ISOLATED FROM LEAVES OF CAMELLIA SINENSIS | 2016-06-02 |
20160151435 | PHARMACEUTICAL COMPOSITION ADJUVANT TO CHEMOTHERAPY DRUGS AND APPLICATIONS THEREOF | 2016-06-02 |
20160151436 | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | 2016-06-02 |
20160151437 | NUTRITIONAL SUPPLEMENTS FOR IMPROVED VISION AND METHODS OF TREATING THE SAME | 2016-06-02 |
20160151438 | Synergistic formulation for relieving gout symptoms | 2016-06-02 |
20160151439 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING OBESITY, CONTAINING GREEN-TEA SEE HUSK EXTRACT AS ACTIVE INGREDIENT | 2016-06-02 |
20160151440 | A Novel Composition of Curcumin with Enhanced Bioavailability | 2016-06-02 |
20160151441 | FORMULATIONS CONTAINING EXTRACTS OF ECHINACEA ANGUSTIFOLIA AND ZINGIBER OFFICINALE WHICH ARE USEFUL IN REDUCING INFLAMMATION AND PERIPHERAL PAIN | 2016-06-02 |
20160151442 | COMPOSITIONS COMPRISING NECROSIS INHIBITORS, SUCH AS NECROSTATINS, ALONE OR IN COMBINATION, FOR PROMOTING AXON REGENERATION AND NERVE FUNCTION, THEREBY TREATING CNS DISORDERS | 2016-06-02 |
20160151443 | METHOD FOR MEDICAL TREATMENT UTILIZING GLUTATHIONE | 2016-06-02 |
20160151444 | METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY | 2016-06-02 |
20160151445 | METHODS FOR THE REGULATION OF MATRIX METALLOPROTEINASE EXPRESSION | 2016-06-02 |
20160151446 | PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME | 2016-06-02 |
20160151447 | PHARMACEUTICAL COMPOSITION FOR A SUSTAINED RELEASE OF LANREOTIDE | 2016-06-02 |
20160151448 | MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS | 2016-06-02 |
20160151449 | USE OF TIGHT JUNCTION ANTAGONISTS TO TREAT INFLAMMATORY BOWEL DISEASE | 2016-06-02 |
20160151450 | Compositions and Methods for Treating Neuropsychiatric Disorders Using an Endothelin-B Receptor Agonist | 2016-06-02 |
20160151451 | METHOD FOR GENERATING CARDIOMYOCYTES | 2016-06-02 |
20160151452 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO EPHRIN SIGNALING WITH CUPREDOXINS AND MUTANTS THEREOF | 2016-06-02 |
20160151453 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS | 2016-06-02 |
20160151454 | LEUKOLECTINS AND USES THEREOF | 2016-06-02 |
20160151455 | Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use | 2016-06-02 |
20160151456 | LIPOPEPTIDE INHIBITORS OF RAS ONCOPROTEINS | 2016-06-02 |
20160151457 | OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2016-06-02 |
20160151458 | Use Of Unacylated Ghrelin, Fragments And Analogs Thereof As Antioxidant | 2016-06-02 |
20160151459 | THERAPEUTIC METHOD OF TREATING METABOLIC DISORDERS | 2016-06-02 |
20160151460 | Method of treating skeletal dysplasias using vessel dilator | 2016-06-02 |
20160151461 | Cardio-Metabolic and Vascular Effects of GLP-1 Metabolites | 2016-06-02 |
20160151462 | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | 2016-06-02 |
20160151463 | COMBINATION TREATMENT FOR ATOPIC DERMATITIS | 2016-06-02 |
20160151464 | LOW VISCOSITY COMPOSITIONS COMPRISING A PEGYLATED GLA-DOMAIN CONTAINING PROTEIN | 2016-06-02 |
20160151465 | METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES | 2016-06-02 |
20160151466 | BOTULINUM NEUROTOXINS WITH MODIFIED LIGHT CHAIN SPECIFITY AND METHODS FOR PRODUCING SAME | 2016-06-02 |
20160151467 | COMPOSITION COMPRISING FILLER AND BOTULINUM TOXIN FOR ALLEVIATING SKIN WRINKLES OR AGING OR TREATING NEUROMUSCULAR DISEASES | 2016-06-02 |
20160151468 | Suture Line Administration Technique Using Botulinum Toxins | 2016-06-02 |
20160151469 | IMMUNE MODULATION BY TLR ACTIVATION FOR TREATMENT OF FILOVIRUS INFECTIONS INCLUDING EBOLA | 2016-06-02 |
20160151470 | T-CELL IMMUNOGENS DERIVED FROM ANTI-VIRAL PROTEINS AND METHODS OF USING SAME | 2016-06-02 |
20160151471 | INDUCIBLE REGULATORY T-CELL GENERATION FOR HEMATOPOIETIC TRANSPLANTS | 2016-06-02 |
20160151472 | METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER OR INDUCING A HUMORAL IMMUNE RESPONSE AGAINST PROSTATE CANCER | 2016-06-02 |
20160151473 | Vaccines Using High-Dose Cytokines | 2016-06-02 |
20160151474 | VACCINATION IN ELDERLY PATIENTS | 2016-06-02 |
20160151475 | Bacterial Ribonucleic Acid Cell Wall Compositions and Methods of Making and Using Them | 2016-06-02 |
20160151476 | COMBINATION NEISSERIAL COMPOSITIONS | 2016-06-02 |
20160151477 | DENGUE VIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2016-06-02 |
20160151478 | Novel Flavivirus Antigens | 2016-06-02 |
20160151479 | METHOD FOR PREPARING VIROSOMES | 2016-06-02 |
20160151480 | Universal Influenza Vaccine | 2016-06-02 |
20160151481 | PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF | 2016-06-02 |
20160151482 | MESOPOROUS ALUM NANOPARTICLES AS A UNIVERSAL PLATFORM FOR ANTIGEN ADSORPTION, PRESENTATION, AND DELIVERY | 2016-06-02 |
20160151483 | BETA-GLYCOLIPIDS FOR USE AS ADJUVANTS | 2016-06-02 |
20160151484 | METHODS AND FORMULATIONS WHICH ALLOW THE MODULATION OF IMMUNE RESPONSES RELATED TO THE ADMINISTRATION OF A BIOPHARMACEUTICAL DRUG | 2016-06-02 |
20160151485 | POLYSACCHARIDE SUITABLE TO MODULATE IMMUNE RESPONSE | 2016-06-02 |
20160151486 | CD40 Signalling Inhibitor and a Further Compound, Wherein the Further Compound is a Bile Acid, a Bile Acid Derivative, an TGR5-Receptor Agonist, an FXR Agonist or a Combination Thereof, for the Treatment of Chronic Inflammation, and the Prevention of Gastrointestinal Cancer or Fibrosis | 2016-06-02 |
20160151487 | FCRN-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR EYE DISEASES | 2016-06-02 |
20160151488 | Methods for Treating Juvenile Idiopathic Arthritis | 2016-06-02 |
20160151489 | COMBINATION OF A LIGAND OF HVEM AND AN IMMUNOTOXIN FOR USE IN THERAPY | 2016-06-02 |
20160151490 | METHODS AND COMPOSITIONS FOR TREATING CANCER | 2016-06-02 |
20160151491 | CELLS PREPARED BY TRANSIENT TRANSFECTION AND METHODS OF USE THEREOF | 2016-06-02 |
20160151492 | Monoclonal Antibodies for Ebola and Marburg Viruses | 2016-06-02 |
20160151493 | Heating Elements Having Plasmonic Nanoparticles for Localized Heating | 2016-06-02 |
20160151494 | TARGETING THYMIDINE KINASE PHOTOSENSITIZER AND PHARMACEUTICAL COMPOSITION AND USE FOR CANCER TREATMENT THEREOF | 2016-06-02 |
20160151495 | IMMUNOGLOBULIN PREPARATION | 2016-06-02 |
20160151496 | SUSTAINED RELEASE EYE DROP FORMULATIONS | 2016-06-02 |
20160151497 | pH SENSITIVE CARRIER AND PREPARATION METHOD THEREOF, AND pH SENSITIVE DRUG AND pH SENSITIVE DRUG COMPOSITION EACH CONTAINING THE CARRIER, AND METHOD FOR TREATING OR PREVENTING DISEASES USING THE SAME | 2016-06-02 |
20160151498 | Nanoparticle Compositions | 2016-06-02 |
20160151499 | Pharmaceutical Formulation Containing Gelling Agent | 2016-06-02 |
20160151500 | METHOD FOR THE TREATMENT OF NANOHYDROGELS | 2016-06-02 |
20160151501 | POWDER MIXTURES FOR ANTIBIOTIC DRY SYRUP FORMULATIONS | 2016-06-02 |
20160151502 | Pharmaceutical Formulation Containing Gelling Agent | 2016-06-02 |
20160151503 | COMPOSITIONS AND PREPARATION METHODS OF LOW MELTING IONIC SALTS OF POORLY-WATER SOLUBLE DRUGS | 2016-06-02 |
20160151504 | PEPTIDES USEFUL AS CELL-PENETRATING PEPTIDES | 2016-06-02 |
20160151505 | BIO-ORTHOGONAL DRUG ACTIVATION | 2016-06-02 |
20160151506 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | 2016-06-02 |
20160151507 | METHODS AND COMPOSITIONS RELATED TO IMMUNOGENIC FIBRILS | 2016-06-02 |
20160151508 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | 2016-06-02 |
20160151509 | ENZYME AND RECEPTOR MODULATION | 2016-06-02 |
20160151510 | PROTEINS AND PROTEIN CONJUGATES WITH INCREASED HYDROPHOBICITY | 2016-06-02 |
20160151511 | PROTEINS AND PROTEIN CONJUGATES WITH INCREASED HYDROPHOBICITY | 2016-06-02 |
20160151512 | Cell-Penetrating Peptide, Conjugate Comprising Same and Composition Comprising Same | 2016-06-02 |
20160151513 | METHODS OF DELIVERING DLL3 ANTIBODY DRUG CONJUGATES | 2016-06-02 |
20160151514 | LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY | 2016-06-02 |
20160151515 | NOVEL ANTIBODY-DRUG CONJUGATES AND THE USE OF SAME IN THERAPY | 2016-06-02 |
20160151516 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS | 2016-06-02 |
20160151517 | Probes for Imaging of Hypoxia | 2016-06-02 |
20160151518 | RADIOLABELLED MATERIAL | 2016-06-02 |
20160151519 | SELECTIN LIGANDS USEFUL IN THE DIAGNOSIS AND TREATMENT OF CANCER | 2016-06-02 |
20160151520 | DEVICE FOR STERILIZING EVAPORATOR CORE OF AIR CONDITIONING SYSTEM | 2016-06-02 |
20160151521 | DEVICE FOR ULTRAVIOLET AND COLOR LIGHT EMISSION | 2016-06-02 |
20160151522 | LAMP DEVICE, SUBSTRATE CLEANING APPARATUS AND OPERATION METHOD THEREOF | 2016-06-02 |